These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 11160247

  • 21. TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus.
    Washburn B, Weigand MA, Grosse-Wilde A, Janke M, Stahl H, Rieser E, Sprick MR, Schirrmacher V, Walczak H.
    J Immunol; 2003 Feb 15; 170(4):1814-21. PubMed ID: 12574346
    [Abstract] [Full Text] [Related]

  • 22. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
    Qin JZ, Bacon P, Chaturvedi V, Nickoloff BJ.
    J Invest Dermatol; 2001 Oct 15; 117(4):898-907. PubMed ID: 11676830
    [Abstract] [Full Text] [Related]

  • 23. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M, Ganea D.
    J Immunol; 2001 Jan 15; 166(2):1028-40. PubMed ID: 11145682
    [Abstract] [Full Text] [Related]

  • 24. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H.
    J Immunol; 1999 Mar 01; 162(5):2639-47. PubMed ID: 10072506
    [Abstract] [Full Text] [Related]

  • 25. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.
    Apolloni E, Bronte V, Mazzoni A, Serafini P, Cabrelle A, Segal DM, Young HA, Zanovello P.
    J Immunol; 2000 Dec 15; 165(12):6723-30. PubMed ID: 11120790
    [Abstract] [Full Text] [Related]

  • 26. Receptor activator of nuclear factor kappaB ligand plays a nonredundant role in doxorubicin-induced apoptosis.
    Müller I, Pfister SM, Grohs U, Zweigner J, Handgretinger R, Niethammer D, Bruchelt G.
    Cancer Res; 2003 Apr 15; 63(8):1772-5. PubMed ID: 12702561
    [Abstract] [Full Text] [Related]

  • 27. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
    Teh HS, Seebaran A, Teh SJ.
    J Immunol; 2000 Nov 01; 165(9):4814-21. PubMed ID: 11046004
    [Abstract] [Full Text] [Related]

  • 28. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage.
    Mariani SM, Krammer PH.
    Eur J Immunol; 1998 Mar 01; 28(3):973-82. PubMed ID: 9541592
    [Abstract] [Full Text] [Related]

  • 29. TRAIL-induced signalling and apoptosis.
    MacFarlane M.
    Toxicol Lett; 2003 Apr 04; 139(2-3):89-97. PubMed ID: 12628743
    [Abstract] [Full Text] [Related]

  • 30. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.
    J Immunol; 1999 Aug 15; 163(4):1906-13. PubMed ID: 10438925
    [Abstract] [Full Text] [Related]

  • 31. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
    Ahmad M, Shi Y.
    Oncogene; 2000 Jul 13; 19(30):3363-71. PubMed ID: 10918593
    [Abstract] [Full Text] [Related]

  • 32. Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis.
    Velthuis JH, Rouschop KM, De Bont HJ, Mulder GJ, Nagelkerke JF.
    J Biol Chem; 2002 Jul 05; 277(27):24631-7. PubMed ID: 11980895
    [Abstract] [Full Text] [Related]

  • 33. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N, Maeda H, Yoshimine Y, Akamine A.
    Bone; 2004 Sep 05; 35(3):629-35. PubMed ID: 15336598
    [Abstract] [Full Text] [Related]

  • 34. The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells.
    Franco AV, Zhang XD, Van Berkel E, Sanders JE, Zhang XY, Thomas WD, Nguyen T, Hersey P.
    J Immunol; 2001 May 01; 166(9):5337-45. PubMed ID: 11313369
    [Abstract] [Full Text] [Related]

  • 35. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
    Zhang XD, Franco AV, Nguyen T, Gray CP, Hersey P.
    J Immunol; 2000 Apr 15; 164(8):3961-70. PubMed ID: 10754286
    [Abstract] [Full Text] [Related]

  • 36. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
    Shiraki K, Yamanaka T, Inoue H, Kawakita T, Enokimura N, Okano H, Sugimoto K, Murata K, Nakano T.
    Int J Oncol; 2005 May 15; 26(5):1273-81. PubMed ID: 15809718
    [Abstract] [Full Text] [Related]

  • 37. Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.
    van Geelen CM, de Vries EG, Le TK, van Weeghel RP, de Jong S.
    Br J Cancer; 2003 Jul 21; 89(2):363-73. PubMed ID: 12865931
    [Abstract] [Full Text] [Related]

  • 38. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis.
    Muta H, Boise LH, Fang L, Podack ER.
    J Immunol; 2000 Nov 01; 165(9):5105-11. PubMed ID: 11046041
    [Abstract] [Full Text] [Related]

  • 39. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis.
    Felli N, Pedini F, Zeuner A, Petrucci E, Testa U, Conticello C, Biffoni M, Di Cataldo A, Winkles JA, Peschle C, De Maria R.
    J Immunol; 2005 Aug 01; 175(3):1464-72. PubMed ID: 16034083
    [Abstract] [Full Text] [Related]

  • 40. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
    Dorothée G, Vergnon I, Menez J, Echchakir H, Grunenwald D, Kubin M, Chouaib S, Mami-Chouaib F.
    J Immunol; 2002 Jul 15; 169(2):809-17. PubMed ID: 12097384
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.